Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > Patent update

<< Previous

Bullboard Posts

Next >>

Comment by stockbuphoonon Mar 16, 2022 12:01pm

163 Views

Post# 34518620

RE:RE:RE:Patent update

Management and Thomvest are doing everything they can to get it delisted. It's an easily telegraphed plan. Thomvest knew the offers on table in 2018 and they pulled off the financial engineering to take over the company in 2019. Now, they are burying anything of perceived value in company such as 4050.